For severe bone-on-bone arthritis, stem cell therapy is not a proven alternative to knee replacement surgery. Patients facing surgery frequently weigh a cash-pay injection against a total knee replacement. For earlier stages of joint wear, an injection is an out-of-pocket gamble that may temporarily relieve pain, but there is no clear proof that it regrows cartilage or removes the eventual need for a joint replacement.
Patients exploring stem cell therapy vs knee replacement often want to know if stem cell therapy is better than knee replacement or if it can serve as a lasting delay tactic. While total knee replacement is major surgery, it is the established option for severe arthritis backed by decades of outcome data. In contrast, stem cell injections remain unapproved by regulators and unsupported by high-certainty trial data for joint repair.
Stem Cell Therapy vs Knee Replacement at a Glance
| Criteria | Stem cell therapy (knee injection) | Knee replacement surgery |
|---|---|---|
| Primary goal | May slightly improve pain and function (low certainty) | Replacement of worn joint surfaces with implants |
| FDA status | No product approved for knee osteoarthritis | A surgical procedure using implants; confirm device status with your surgeon |
| Evidence strength | Low certainty for slight pain relief (2025 Cochrane review) | Decades of outcome data from case series and national registry reports |
| Durability | Unproven; clinic claims of 3 to 6 months building effect | About 82% of implants last 25 years in registry data |
| Typical US cost | $4,000 to $12,000 per knee out of pocket | Varies by facility; no single US price; usually covered by insurance |
| Insurance coverage | Not covered (investigational) | Usually covered by commercial plans and Medicare |
| Procedure type | Outpatient clinic injection with no incision | Major surgery with an incision |
| Cartilage repair | No clear proof of structural change or regrowth | Replaces the worn joint surfaces rather than repairing them |
What the Clinical Evidence Actually Shows
Total knee replacement has decades of outcome data, while stem cell injections offer only low-certainty evidence for slight pain relief. A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up found that about 82% of total knee replacements last 25 years. Surgeons commonly describe implants as lasting roughly 15 to 20 years.
Stem cell injections do not have comparable evidence. A 2025 review by the Cochrane Library, which pooled 25 studies covering 1,341 people, examined stem cell injections for knee osteoarthritis. The reviewers concluded that, compared with placebo, stem cell injections may slightly improve pain and function, but that finding rested entirely on low-certainty evidence. As detailed in the Cochrane evidence summary, the authors remained uncertain about patient quality of life and overall treatment success. The review found no clear proof that stem cell injections change the internal structure of the knee or regrow cartilage.
Regulators take a similar view. The Food and Drug Administration (FDA) has not approved any stem cell product for knee osteoarthritis, as outlined in the official FDA consumer alert on regenerative medicine therapies. Clinics sell these treatments unapproved. Read our detailed guide to stem cell therapy to understand how these clinics operate.
The Cost Gap Between Cash Pay and Insurance
Stem cell knee injections are paid entirely out of pocket, whereas knee replacement surgery is covered by most health plans when medically necessary. A single stem cell knee injection generally runs $4,000 to $8,000 per knee. If a clinic offers cultured cells or more complex cell preparations, the bill can reach $12,000 for one knee. Treating both knees pushes the bill to $8,000 to $16,000. Because many regenerative clinics recommend a second booster injection at six months, a patient’s cash outlay can easily double in the first year alone.
Insurance does not cover stem cell injections, treating them as investigational. Readers can review our guides on knee stem cell therapy costs and insurance coverage rules to see how claims are handled.
Knee replacement surgery presents the opposite financial structure. No single US price is available for surgery, and the total bill varies widely by facility. The total bill is far higher than the price of a cash-pay injection. However, commercial health insurance and Medicare usually cover most of the bill when the surgery is medically necessary. Patients can check national average costs and copays by facility type through the official Medicare Procedure Price Lookup tool. For more details on coverage, see our breakdown of what Medicare covers.
Recovery Timelines and Procedural Risks
Stem cell injections involve a brief outpatient recovery with mild side effects, while knee replacement requires major surgical rehabilitation. A stem cell injection is an outpatient procedure. It requires no incision and no hospital stay. Patients usually experience local soreness, mild swelling, or stiffness around the injection site for a few days. Clinics typically instruct patients to avoid running, heavy loading, and deep squats for one to two weeks. Clinics say results build over three to six months, which makes it hard to separate a real effect from normal recovery, rest, and placebo response. Injection risks include temporary pain and bruising. Serious complications like infection or immune reactions are rarer when using a patient’s own tissue, but they emerge more frequently with donor products or poorly screened clinics. Read more on stem cell therapy safety and side effects.
Total knee replacement is major surgery that replaces the worn joint surfaces of the knee with implants. The patient must complete a structured physical therapy (PT) program directed by their surgical team. The surgeon’s timeline governs recovery. Surgical risks include infection, blood clots, and, over years, implant wear or loosening that can require revision surgery.
Other Knee Replacement Alternatives to Consider First
Several lower-cost, insured knee replacement alternatives exist that are worth weighing before an expensive cash injection. Physical therapy typically costs $50 to $150 per visit, is often insured, and has strong clinical evidence.
Cortisone injections offer good short-term relief for $100 to $400, and they are often covered by insurance. Hyaluronic acid injections cost $300 to $1,500, are sometimes insured, and have modest evidence. Platelet-rich plasma (PRP) injections cost $500 to $2,500 out of pocket and are rarely insured. While PRP evidence remains mixed, evidence shows some knee benefit, as explored in our guide on PRP for knee osteoarthritis and our breakdown of PRP vs stem cell therapy.
Another emerging option is genicular artery embolization. This newer option blocks small arteries feeding the inflamed joint lining. It has early trial data showing pain reduction, though it does not regrow cartilage. None of these intermediate options, including stem cell therapy, have been proven to prevent an eventual knee replacement once arthritis reaches an advanced stage. You can read more about evaluating these procedures on our knees condition hub.
A Simple Way to Decide Whether to Delay Surgery
Deciding whether to postpone a total knee replacement comes down to joint anatomy, age, and personal finances. Delaying surgery makes medical sense when a joint still has functional cartilage left to protect. It turns into an expensive mistake when the joint is already bone-on-bone.
- What does your imaging show? Partial cartilage loss leaves something to protect. If your joint surfaces are grinding bone-on-bone, biological injections have nothing left to protect, and delaying surgery will not improve your eventual surgical outcome.
- How old are you? Because joint replacements are commonly described as lasting roughly 15 to 20 years, surgeons often support delaying surgery for patients in their forties and fifties. For patients past about 65, that reasoning weakens.
- What is the financial and functional cost of waiting? Weigh what you are spending on injections, lost function, and months of pain against a surgery your insurer covers.
A common failure mode involves a patient spending roughly $8,000 over two years on injections to delay an operation they end up having anyway on a joint that was already bone-on-bone at their first consultation. Before paying for an injection, demand that the clinic point out the remaining cartilage on your own diagnostic imaging. Use our guide to vetting a regenerative clinic before deciding.
Who This Is Not For
Stem cell therapy is the wrong choice for anyone with severe, bone-on-bone knee osteoarthritis who expects the injection to rebuild cartilage or restore normal joint anatomy. Patients with severe, bone-on-bone arthritis should consider knee replacement rather than unproven delay.
Conversely, delaying surgery is reasonable when the joint still has cartilage left.
What Would Change This Answer
A well-controlled, randomized clinical trial demonstrating that stem cell injections produce durable cartilage regrowth on follow-up magnetic resonance imaging would fundamentally alter this evaluation. If peer-reviewed trials confirmed structural repair alongside lasting pain relief, stem cell injections could serve as a genuine biological alternative to joint arthroplasty.
On the surgical side, evidence showing that implant durability drops sharply below the 82% 25-year benchmark would push younger patients to delay surgery even longer. For now, the clinical data establishes joint replacement as a proven mechanical solution, while stem cell therapy remains an unproven, self-pay gamble. Review our analysis on whether stem cell therapy is worth it to weigh these trade-offs further.
The Bottom Line on Stem Cell Therapy vs Knee Replacement
Knee replacement surgery remains the established option for severe joint arthritis, backed by outcome data showing that about 82% of implants endure for 25 years. Stem cell therapy is an expensive, out-of-pocket procedure supported only by low-certainty evidence of slight pain relief, with no documented capacity to repair cartilage or permanently avoid surgery.
If your imaging shows moderate arthritis and you want to delay an operation while you are in your fifties, an injection may slightly improve pain, on low-certainty evidence, if you can afford to pay for it with no insurance help. If your knee is already bone-on-bone, review costs through the Medicare Procedure Price Lookup tool, consult an orthopedic surgeon, and calculate your out-of-pocket costs before spending thousands on a stem cell injection.
Frequently asked questions
Is stem cell therapy better than knee replacement?
No, clinical trials do not show that stem cell therapy is better than knee replacement for restoring joint function or relieving severe arthritis. Total knee replacement is an established procedure with long-term registry data showing that about 82% of implants last 25 years, whereas a 2025 Cochrane review found stem cell therapy provides only low-certainty evidence for slight pain relief.
Can stem cell therapy delay knee replacement surgery?
The 2025 Cochrane review found stem cell injections may slightly improve pain and function, on low-certainty evidence, so any help postponing surgery is uncertain. However, clinical studies have not proven that stem cell injections regrow cartilage or remove the eventual need for surgery in an advanced knee.
Which option costs more out of pocket?
A stem cell injection costs $4,000 to $12,000 per knee, all paid out of pocket. Knee replacement has a far higher total bill, but insurance and Medicare usually cover most of it when the surgery is medically necessary, so your own share depends on your plan and facility. Medicare's Procedure Price Lookup shows national average costs and copays by facility type.
Does insurance or Medicare cover knee stem cell injections?
No, private insurance companies and Medicare do not cover stem cell injections for knee osteoarthritis. They treat stem cell procedures as investigational, and no stem cell product is FDA-approved for knee osteoarthritis.
How long does each treatment last?
A systematic review of joint registries shows that roughly 82% of total knee replacements last 25 years. In contrast, the duration of stem cell therapy is unproven, though clinics say results build over three to six months.
Is stem cell therapy safer than total knee replacement?
Stem cell therapy is an outpatient injection with risks like pain, swelling, and bruising, while knee replacement involves surgical risks such as infection and blood clots. However, the 2025 Cochrane review flagged uncertainty about safety.
Is stem cell therapy an alternative if my knee is bone-on-bone?
No, stem cell therapy is not an effective alternative for a bone-on-bone knee joint. When a joint is bone-on-bone, stem cell injections have no clear proof of regrowing cartilage, and knee replacement is the established option.
Medical disclaimer. Medical Frontier is an independent educational resource. This page is for general information only and is not medical advice, diagnosis, or treatment, and does not create a doctor–patient relationship. Most regenerative therapies discussed here are not FDA-approved for the uses described and may be offered under limited exemptions or in clinical trials only. Always consult a licensed physician before making any treatment decision.